Dalbagni, G., Benfante, N., Sjoberg, D. D., Bochner, B. H., Machele Donat, S., Herr, H. W., . . . Bajorin, D. F. (2017). Single Arm Phase I/II Study of Everolimus and Intravesical Gemcitabine in Patients with Primary or Secondary Carcinoma In Situ of the Bladder who failed Bacillus Calmette Guerin (NCT01259063). Bladder Cancer.
Citação norma ChicagoDalbagni, Guido, et al. "Single Arm Phase I/II Study of Everolimus and Intravesical Gemcitabine in Patients With Primary or Secondary Carcinoma In Situ of the Bladder Who Failed Bacillus Calmette Guerin (NCT01259063)." Bladder Cancer 2017.
MLA citiranjeDalbagni, Guido, et al. "Single Arm Phase I/II Study of Everolimus and Intravesical Gemcitabine in Patients With Primary or Secondary Carcinoma In Situ of the Bladder Who Failed Bacillus Calmette Guerin (NCT01259063)." Bladder Cancer 2017.